BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY, Zheng MH. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol 2020;8:18-24. [PMID: 32274342 DOI: 10.14218/JCTH.2020.00018] [Cited by in Crossref: 148] [Cited by in F6Publishing: 118] [Article Influence: 74.0] [Reference Citation Analysis]
Number Citing Articles
1 Licata A, Minissale MG, Distefano M, Montalto G. Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 2021;3:121-30. [PMID: 34149320 DOI: 10.1002/ygh2.455] [Reference Citation Analysis]
2 Bzeizi K, Abdulla M, Mohammed N, Alqamish J, Jamshidi N, Broering D. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis. Sci Rep 2021;11:10599. [PMID: 34012016 DOI: 10.1038/s41598-021-89513-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Aydin A, Cebi G, Demirtas ZE, Erkus H, Kucukay A, Ok M, Sakalli L, Alpdagtas S, Gunduz O, Ustundag CB. Combating COVID-19 with tissue engineering: a review. Emergent Mater 2020;:1-21. [PMID: 33235976 DOI: 10.1007/s42247-020-00138-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zaki MM, Lesha E, Said K, Kiaee K, Robinson-McCarthy L, George H, Hanna A, Appleton E, Liu S, Ng AHM, Khoshakhlagh P, Church GM. Cell therapy strategies for COVID-19: Current approaches and potential applications. Sci Adv 2021;7:eabg5995. [PMID: 34380619 DOI: 10.1126/sciadv.abg5995] [Reference Citation Analysis]
5 El-Ghiaty MA, Shoieb SM, El-Kadi AOS. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms. Med Hypotheses 2020;144:110033. [PMID: 32758877 DOI: 10.1016/j.mehy.2020.110033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
6 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
7 Wiśniewska H, Skonieczna-Żydecka K, Parczewski M, Niścigorska-Olsen J, Karpińska E, Hornung M, Jurczyk K, Witak-Jędra M, Laurans Ł, Maciejewska K, Socha Ł, Leonciuk A, Bander D, Karasińska-Cieślak M, Aksak-Wąs B, Wawrzynowicz-Syczewska M. Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic. J Clin Med 2021;10:672. [PMID: 33572429 DOI: 10.3390/jcm10040672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lonardo A, Ballestri S. Perspectives of nonalcoholic fatty liver disease research: a personal point of view. Exploration of Medicine 2020;1:85-107. [DOI: 10.37349/emed.2020.00007] [Reference Citation Analysis]
9 Cordeiro A, Ribamar A, Ramalho A. ADIPOSE TISSUE DYSFUNCTION AND MAFLD IN OBESITY ON THE SCENE OF COVID-19. Clin Res Hepatol Gastroenterol 2021;:101807. [PMID: 34543756 DOI: 10.1016/j.clinre.2021.101807] [Reference Citation Analysis]
10 Lamazou F, Oger P, Dieli-Crimi R, Guerin A, Letouzey V, Octernaud S, Place V, Calès P, Descamps P, Delaroche L. COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report. BMC Infect Dis 2020;20:845. [PMID: 33198681 DOI: 10.1186/s12879-020-05551-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D'Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.J Infect Dis. 2020;222:1807-1815. [PMID: 32914853 DOI: 10.1093/infdis/jiaa578] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
12 Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection . World J Hepatol 2021; 13(12): 1909-1918 [DOI: 10.4254/wjh.v13.i12.1909] [Reference Citation Analysis]
13 Azer SA. COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020;37:100738. [PMID: 32834902 DOI: 10.1016/j.nmni.2020.100738] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
14 Beni ZN, Beni AN, Samani FR, Dayani MA, Beni FN, Radmehr H, Noorshargh P. Multivariable analysis of clinical and laboratory data manifestations predicting severity and mortality risk in patients with Coronavirus disease 2019 in the mountainous west of Iran: a retrospective single-center study. Asian Biomedicine 2022;16:31-42. [DOI: 10.2478/abm-2022-0005] [Reference Citation Analysis]
15 Li Z, Wu Y, Qi X. Comments on the "WGO Guidance for the Care of Patients With COVID-19 and Liver Disease". J Clin Gastroenterol 2021;55:638. [PMID: 34227618 DOI: 10.1097/MCG.0000000000001508] [Reference Citation Analysis]
16 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Reference Citation Analysis]
17 Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
19 Chinni V, El-Khoury J, Perera M, Bellomo R, Jones D, Bolton D, Ischia J, Patel O. Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunities. Br J Clin Pharmacol 2021. [PMID: 33742473 DOI: 10.1111/bcp.14826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19. Biomolecules 2022;12:21. [DOI: 10.3390/biom12010021] [Reference Citation Analysis]
22 Maev IV, Shpektor AV, Vasilyeva EY, Manchurov VN, Andreev DN. [Novel coronavirus infection COVID-19: extrapulmonary manifestations]. Ter Arkh 2020;92:4-11. [PMID: 33346454 DOI: 10.26442/00403660.2020.08.000767] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Olson MC, Lubner MG, Menias CO, Mellnick VM, Gettle LM, Kim DH, Elsayes KM, Pickhardt PJ. RadioGraphics Update: Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis-Findings in COVID-19. Radiographics 2020;40:E24-8. [PMID: 32649264 DOI: 10.1148/rg.2020200119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
24 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
25 Ussaid A, Riaz B, Rafai W, Anwar S, Baig F, Saleem K, Pervaiz F, Firdous Z, Nasir SA, Iqbal F. Clinical Characteristics of 47 Death Cases With COVID-19: A Retrospective Study at a Tertiary Center in Lahore. Cureus 2020;12:e12039. [PMID: 33457138 DOI: 10.7759/cureus.12039] [Reference Citation Analysis]
26 Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M; APASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int 2020;14:690-700. [PMID: 32623632 DOI: 10.1007/s12072-020-10072-8] [Cited by in Crossref: 91] [Cited by in F6Publishing: 1] [Article Influence: 45.5] [Reference Citation Analysis]
27 Ten-Caten F, Gonzalez-Dias P, Castro Í, Ogava RLT, Giddaluru J, Silva JCS, Martins F, Gonçalves ANA, Costa-Martins AG, Araujo JD, Viegas AC, Cunha FQ, Farsky S, Bozza FA, Levin AS, Pannaraj PS, de Silva TI, Minoprio P, Pinheiro da Silva F, Andrade BB, Nakaya HI. In-depth analysis of laboratory parameters reveals the interplay between sex, age, and systemic inflammation in individuals with COVID-19. Int J Infect Dis 2021;105:579-87. [PMID: 33713813 DOI: 10.1016/j.ijid.2021.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
28 Lee A, Wein AN, Doyle MBM, Chapman WC. Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep 2021;14:e244168. [PMID: 34446515 DOI: 10.1136/bcr-2021-244168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Reference Citation Analysis]
30 Chu Y, Yang J, Shi J, Zhang P, Wang X. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. Eur J Med Res 2020;25:64. [PMID: 33267871 DOI: 10.1186/s40001-020-00464-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
31 Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations. EPMA J 2020;11:505-15. [PMID: 32839667 DOI: 10.1007/s13167-020-00221-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
32 Li QY, An ZY, Li C, Zu M, Chen L, Zhang JN, Zhao YY, Shen N, Ge QG. Chronic Active Hepatitis B with COVID-19 in Pregnancy: A Case Report. J Clin Transl Hepatol 2021;9:133-5. [PMID: 33604264 DOI: 10.14218/JCTH.2020.00085] [Reference Citation Analysis]
33 Stawinski PM, Dziadkowiec KN, Al-Abbasi B, Suarez L, Simms L, Dewaswala N, Torres P, Al Rubaye A, Pino J, Marcus A. Model of End-Stage Liver Disease (MELD) Score as a Predictor of In-Hospital Mortality in Patients with COVID-19: A Novel Approach to a Classic Scoring System. Cureus 2021;13:e15179. [PMID: 34178500 DOI: 10.7759/cureus.15179] [Reference Citation Analysis]
34 Kardani K, Bolhassani A, Kardani M, Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. JoMMID 2021;9:122-32. [DOI: 10.52547/jommid.9.3.122] [Reference Citation Analysis]
35 Xia HH, Wu GY, Ren H. Journal of Clinical and Translational Hepatology Has Been Indexed in SCIE: A Milestone towards a Greater Academic Goal. J Clin Transl Hepatol 2020;8:357-8. [PMID: 33447517 DOI: 10.14218/JCTH.2020.00138] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Garland V, Kumar AB, Borum ML. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations. J Natl Med Assoc. 2021;113:142-146. [PMID: 32807512 DOI: 10.1016/j.jnma.2020.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Nie XB, Shi BS, Zhang L, Niu WL, Xue T, Li LQ, Wei XY, Wang YD, Chen WD, Hou RF. Epidemiological features and dynamic changes in blood biochemical indices for COVID-19 patients in Hebi. World J Clin Cases 2022; 10(8): 2404-2419 [DOI: 10.12998/wjcc.v10.i8.2404] [Reference Citation Analysis]
38 Verma HK, Bhaskar L. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted. World J Gastroenterol 2021; 27(45): 7855-7858 [PMID: 34963747 DOI: 10.3748/wjg.v27.i45.7855] [Reference Citation Analysis]
39 Sies H, Parnham MJ. Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. Free Radic Biol Med 2020;156:107-12. [PMID: 32598985 DOI: 10.1016/j.freeradbiomed.2020.06.032] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 26.0] [Reference Citation Analysis]
40 Ozkurt Z, Çınar Tanrıverdi E. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World J Clin Cases 2022; 10(4): 1140-1163 [DOI: 10.12998/wjcc.v10.i4.1140] [Reference Citation Analysis]
41 Mnatsakanyan MG, Pogromov AP, Lishuta AS, Fomin VV, Volkova OS, Tashchyan OV, Kuprina IV, Shumskaya YF. Liver and COVID-19: possible mechanisms of damage. Terapevticheskii arkhiv 2021;93:427-30. [DOI: 10.26442/00403660.2021.04.200733] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Chen LZ, Lin ZH, Chen J, Liu SS, Shi T, Xin YN. Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19? Epidemiol Infect. 2020;148:e218. [PMID: 32951624 DOI: 10.1017/s0950268820002186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
44 Bahrami A, Arabestani MR, Taheri M, Farmany A, Zadeh FN, Hosseini SM, Nozari H, Nouri F. Exploring the Role of Heavy Metals and Their Derivatives on the Pathophysiology of COVID-19. Biol Trace Elem Res 2021. [PMID: 34448983 DOI: 10.1007/s12011-021-02893-x] [Reference Citation Analysis]
45 Bender JM, Worman HJ. Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City. J Clin Transl Hepatol 2021;9:551-8. [PMID: 34447685 DOI: 10.14218/JCTH.2020.00171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
47 Ziaee A, Azarkar G, Ziaee M. Role of fatty liver in coronavirus disease 2019 patients' disease severity and hospitalization length: a case-control study. Eur J Med Res 2021;26:115. [PMID: 34565475 DOI: 10.1186/s40001-021-00590-y] [Reference Citation Analysis]
48 Wagner J, Garcia-Rodriguez V, Yu A, Dutra B, Larson S, Cash B, DuPont A, Farooq A. Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity. Sci Rep 2021;11:10308. [PMID: 33986318 DOI: 10.1038/s41598-021-89340-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Alyamani OA, Bahatheq MS, Azzam HA, Hilal FM, Farsi S, Bahaziq W, Alshoaiby AN. Perioperative pain management in COVID-19 patients: Considerations and recommendations by the Saudi Anesthesia Society (SAS) and Saudi Society of Pain Medicine (SSPM). Saudi J Anaesth 2021;15:59-69. [PMID: 33824647 DOI: 10.4103/sja.SJA_765_20] [Reference Citation Analysis]
50 Mukherjee PK, Efferth T, Das B, Kar A, Ghosh S, Singha S, Debnath P, Sharma N, Bhardwaj PK, Haldar PK. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine 2022;98:153930. [PMID: 35114450 DOI: 10.1016/j.phymed.2022.153930] [Reference Citation Analysis]
51 Boettcher AN, Hammoud DA, Weinberg JB, Agarwal P, Mendiratta-Lala M, Luker GD. Cancer Imaging and Patient Care during the COVID-19 Pandemic.Radiol Imaging Cancer. 2020;2:e200058. [PMID: 33778750 DOI: 10.1148/rycan.2020200058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Hachim MY, Hachim IY, Naeem KB, Hannawi H, Salmi IA, Hannawi S. D-dimer, Troponin, and Urea Level at Presentation With COVID-19 can Predict ICU Admission: A Single Centered Study. Front Med (Lausanne) 2020;7:585003. [PMID: 33363185 DOI: 10.3389/fmed.2020.585003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
54 Penlioglou T, Papachristou S, Papanas N. COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher's Stone? Diabetes Ther. 2020;11:1-3. [PMID: 32382358 DOI: 10.1007/s13300-020-00830-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
55 Chela HK, Pasha SB, Basar O, Daglilar E, Tahan V. Liver in the limelight in the corona (COVID-19) time. World J Clin Cases 2020; 8(16): 3405-3410 [PMID: 32913847 DOI: 10.12998/wjcc.v8.i16.3405] [Reference Citation Analysis]
56 Lu JY, Anand H, Frager SZ, Hou W, Duong TQ. Longitudinal progression of clinical variables associated with graded liver injury in COVID-19 patients. Hepatol Int 2021;15:1018-26. [PMID: 34268650 DOI: 10.1007/s12072-021-10228-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 Philips CA, Mohan N, Ahamed R, Kumbar S, Rajesh S, George T, Mohanan M, Augustine P. One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World J Clin Cases 2020; 8(18): 3956-3970 [PMID: 33024752 DOI: 10.12998/wjcc.v8.i18.3956] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
58 Yang R, Gui X, Zhang Y, Xiong Y. The challenge of resuming classes for young students in Wuhan, China. Expert Rev Respir Med 2020;14:763-6. [PMID: 32375523 DOI: 10.1080/17476348.2020.1761792] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Costa FF, Rosário WR, Ribeiro Farias AC, de Souza RG, Duarte Gondim RS, Barroso WA. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes Metab Syndr 2020;14:809-14. [PMID: 32540733 DOI: 10.1016/j.dsx.2020.06.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 21.5] [Reference Citation Analysis]
60 Kabaçam G, Dayangaç M, Üçbilek E, Erçin CN, Günsar F, Akyıldız M, Akarsu M, Demir M, Kaymakoğlu S, Karasu Z, İdilman R. The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists. Turk J Gastroenterol 2020;31:348-55. [PMID: 32519953 DOI: 10.5152/tjg.2020.20413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Perera M, El Khoury J, Chinni V, Bolton D, Qu L, Johnson P, Trubiano J, McDonald CF, Jones D, Bellomo R, Patel O, Ischia J. Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol. BMJ Open 2020;10:e040580. [PMID: 33268419 DOI: 10.1136/bmjopen-2020-040580] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
62 Liu XP, Guo MM, Liu SF, Kuo HC. Comparison of laboratory data between children with COVID-19 and influenza. Kaohsiung J Med Sci 2021;37:158-9. [PMID: 33452732 DOI: 10.1002/kjm2.12353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis. Indian J Gastroenterol 2020;39:268-84. [PMID: 32749643 DOI: 10.1007/s12664-020-01058-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
64 Laali A, Tabibzadeh A, Esghaei M, Yousefi P, Soltani S, Ajdarkosh H, Mosavi-Jarrahi A, Karbalaie Niya MH. Liver Function Tests Profile in COVID-19 Patients at the Admission Time: A Systematic Review of Literature and Conducted Researches. Adv Biomed Res 2020;9:74. [PMID: 33912490 DOI: 10.4103/abr.abr_73_20] [Reference Citation Analysis]
65 Tao J, Aristotelidis R, Zanowick-Marr A, Chambers LC, McDonald J, Mylonakis EE, Chan PA. Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis. SN Compr Clin Med 2021;:1-12. [PMID: 34396045 DOI: 10.1007/s42399-021-01014-y] [Reference Citation Analysis]
66 Mirmohammadi S, Kianmehr A, Arefi M, Mahrooz A. Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran. New Microbes New Infect 2020;38:100792. [PMID: 33101694 DOI: 10.1016/j.nmni.2020.100792] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Letelier P, Encina N, Morales P, Riffo A, Silva H, Riquelme I, Guzmán N. Role of biochemical markers in the monitoring of COVID-19 patients. J Med Biochem 2021;40:115-28. [PMID: 33776561 DOI: 10.5937/jomb0-29341] [Reference Citation Analysis]
68 Fukuda M, Amano Y, Masumura C, Ogawa M, Inohara H. Development of infectious mononucleosis as an unusual manifestation of COVID-19. Auris Nasus Larynx 2021:S0385-8146(21)00129-2. [PMID: 33906746 DOI: 10.1016/j.anl.2021.04.005] [Reference Citation Analysis]
69 Fadl N, Ali E, Salem TZ. COVID-19: Risk Factors Associated with Infectivity and Severity. Scand J Immunol 2021;93:e13039. [PMID: 33710663 DOI: 10.1111/sji.13039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Kifle ZD, Ayele AG, Enyew EF. Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment. J Environ Public Health 2021;2021:6631721. [PMID: 33953756 DOI: 10.1155/2021/6631721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Ahmed M, Ahmed MH. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World J Clin Cases 2021; 9(17): 4133-4142 [PMID: 34141776 DOI: 10.12998/wjcc.v9.i17.4133] [Reference Citation Analysis]
72 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]
74 Lonardo A, Ballestri S. Perspectives of nonalcoholic fatty liver disease research: a personal point of view. Exploration of Medicine 2020;1:85-107. [DOI: 10.37349/emed.2020.00007] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
75 Huang YK, Li YJ, Li B, Wang P, Wang QH. Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives. World J Gastroenterol 2021; 27(27): 4358-4370 [PMID: 34366609 DOI: 10.3748/wjg.v27.i27.4358] [Reference Citation Analysis]
76 Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res 2020;8:37. [PMID: 32879731 DOI: 10.1186/s40364-020-00217-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
77 Sarli L. The Pandemic from COVID 19: a Lesson that we must not forget. Acta Biomed 2020;91:5-8. [PMID: 32573501 DOI: 10.23750/abm.v91i6-S.10047] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Dehelean CA, Lazureanu V, Coricovac D, Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM, Cretu O. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening. J Clin Med 2020;9:E2084. [PMID: 32630746 DOI: 10.3390/jcm9072084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
79 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Reference Citation Analysis]
80 Reddy GB, Greif DN, Rodriguez J, Best TM, Greditzer HG 4th, Jose J. Clinical Characteristics and Multisystem Imaging Findings of COVID-19: An Overview for Orthopedic Surgeons. HSS J 2020;:1-12. [PMID: 32837414 DOI: 10.1007/s11420-020-09775-3] [Reference Citation Analysis]
81 Mori M, Ikeda N, Taketomi A, Asahi Y, Takesue Y, Orimo T, Ono M, Kuwayama T, Nakamura S, Yamada Y, Kuroda T, Yuzawa K, Hibi T, Nagano H, Unno M, Kitagawa Y. COVID-19: clinical issues from the Japan Surgical Society. Surg Today 2020;50:794-808. [PMID: 32651686 DOI: 10.1007/s00595-020-02047-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
82 Aktas B, Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol 2020;44:265-72. [PMID: 32595361 DOI: 10.3906/biy-2005-102] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
83 Lazova S, Alexandrova T, Gorelyova-Stefanova N, Atanasov K, Tzotcheva I, Velikova T. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study. Microorganisms 2021;9:1958. [PMID: 34576853 DOI: 10.3390/microorganisms9091958] [Reference Citation Analysis]
84 Tee LY, Alhamid SM, Tan JL, Oo TD, Chien J, Galinato P, Tan SY, Humaira S, Fong RKC, Puar TH, Loh WJ, Santosa A, Khoo J, Rosario BH. COVID-19 and Undiagnosed Pre-diabetes or Diabetes Mellitus Among International Migrant Workers in Singapore. Front Public Health 2020;8:584249. [PMID: 33262970 DOI: 10.3389/fpubh.2020.584249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Vasques-Monteiro IML, Souza-Mello V. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. World J Gastroenterol 2021; 27(16): 1738-1750 [PMID: 33967554 DOI: 10.3748/wjg.v27.i16.1738] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Zhao W, Zhang X, Zhu F, Jiang X. Dynamic Changes of Liver Function Indexes in Patients with Different Clinical Types of COVID-19. IJGM 2022;Volume 15:877-84. [DOI: 10.2147/ijgm.s347291] [Reference Citation Analysis]
87 Ahmed M. Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020. Gastroenterology Res 2020;13:89-95. [PMID: 32655724 DOI: 10.14740/gr1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Zheng KI, Gao F, Wang XB, Sun QF, Pan KH, Wang TY, Ma HL, Chen YP, Liu WY, George J, Zheng MH. Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism 2020;108:154244. [PMID: 32320741 DOI: 10.1016/j.metabol.2020.154244] [Cited by in Crossref: 154] [Cited by in F6Publishing: 145] [Article Influence: 77.0] [Reference Citation Analysis]
89 Jimenez-Solem E, Petersen TS, Hansen C, Hansen C, Lioma C, Igel C, Boomsma W, Krause O, Lorenzen S, Selvan R, Petersen J, Nyeland ME, Ankarfeldt MZ, Virenfeldt GM, Winther-Jensen M, Linneberg A, Ghazi MM, Detlefsen N, Lauritzen AD, Smith AG, de Bruijne M, Ibragimov B, Petersen J, Lillholm M, Middleton J, Mogensen SH, Thorsen-Meyer HC, Perner A, Helleberg M, Kaas-Hansen BS, Bonde M, Bonde A, Pai A, Nielsen M, Sillesen M. Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients. Sci Rep 2021;11:3246. [PMID: 33547335 DOI: 10.1038/s41598-021-81844-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
90 Jha NK, Sharma C, Hashiesh HM, Arunachalam S, Meeran MN, Javed H, Patil CR, Goyal SN, Ojha S. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol 2021;12:590201. [PMID: 34054510 DOI: 10.3389/fphar.2021.590201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Huang JF, Zheng KI, George J, Gao HN, Wei RN, Yan HD, Zheng MH. Fatal outcome in a liver transplant recipient with COVID-19. Am J Transplant. 2020;20:1907-1910. [PMID: 32277591 DOI: 10.1111/ajt.15909] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 25.5] [Reference Citation Analysis]
92 He L, Zhao J, Wang L, Liu Q, Fan Y, Li B, Yu YL, Chen C, Li YF. Using nano-selenium to combat Coronavirus Disease 2019 (COVID-19)? Nano Today 2021;36:101037. [PMID: 33250930 DOI: 10.1016/j.nantod.2020.101037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
93 Abdel‐moneim A. COVID ‐19 complications on the digestive system and liver: A current clinical and pathophysiological approach. Adv in Digestive Med. [DOI: 10.1002/aid2.13260] [Reference Citation Analysis]
94 Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J Gastroenterol 2020;26:2286-93. [PMID: 32476793 DOI: 10.3748/wjg.v26.i19.2286] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 46] [Article Influence: 29.5] [Reference Citation Analysis]
95 Erbabacan E, Özdilek A, Beyoğlu ÇA, Altındaş F. Perioperative Anaesthetic Management of Confirmed or Suspected COVID-19 Patients. Turk J Anaesthesiol Reanim 2020;48:180-7. [PMID: 32551444 DOI: 10.5152/TJAR.2020.654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
96 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Burwick RM, Yawetz S, Stephenson KE, Collier AY, Sen P, Blackburn BG, Kojic EM, Hirshberg A, Suarez JF, Sobieszczyk ME, Marks KM, Mazur S, Big C, Manuel O, Morlin G, Rose SJ, Naqvi M, Goldfarb IT, DeZure A, Telep L, Tan SK, Zhao Y, Hahambis T, Hindman J, Chokkalingam AP, Carter C, Das M, Osinusi AO, Brainard DM, Varughese TA, Kovalenko O, Sims MD, Desai S, Swamy G, Sheffield JS, Zash R, Short WR. Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19. Clin Infect Dis 2020:ciaa1466. [PMID: 33031500 DOI: 10.1093/cid/ciaa1466] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
98 Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P, Soran H; Heart UK's Medical Scientific and Research Committee. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 2020;313:126-36. [PMID: 33045618 DOI: 10.1016/j.atherosclerosis.2020.09.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
99 Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52:267-275. [PMID: 32402090 DOI: 10.1111/apt.15813] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 31.0] [Reference Citation Analysis]
100 Jha NK, Sharma C, Meeran MFN, Jha SK, Dwivedi VD, Gupta PK, Dey A, Kesari KK, Ojha S. Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno 2021;1:285-304. [DOI: 10.3390/immuno1030020] [Reference Citation Analysis]
101 Shousha HI, Afify S, Maher R, Asem N, Fouad E, Mostafa EF, Medhat MA, Abdalazeem A, Elmorsy H, Aziz MM, Mohammed RS, Ibrahem M, Elgarem H, Omran D, Hassany M, Elsayed B, Abdelaziz AY, El Kassas M. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study. World J Gastroenterol 2021; 27(40): 6951-6966 [PMID: 34790017 DOI: 10.3748/wjg.v27.i40.6951] [Reference Citation Analysis]
102 Nkeih C, Sisti G, Schiattarella A. Elevated transaminases in a COVID-19 positive patient at term of gestation: a case report. Acta Biomed 2020;91:e2020002. [PMID: 32921751 DOI: 10.23750/abm.v91i3.9796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020;8:582932. [PMID: 33520910 DOI: 10.3389/fpubh.2020.582932] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
104 D'Amico FE, Glavas D, Noaro G, Bassi D, Boetto R, Gringeri E, De Luca M, Cillo U. Case Report: Liver Cysts and SARS-CoV-2: No Evidence of Virus in Cystic Fluid. Front Surg 2021;8:677889. [PMID: 34222319 DOI: 10.3389/fsurg.2021.677889] [Reference Citation Analysis]
105 Chu H, Bai T, Chen L, Hu L, Xiao L, Yao L, Zhu R, Niu X, Li Z, Zhang L, Han C, Song S, He Q, Zhao Y, Zhu Q, Chen H, Schnabl B, Yang L, Hou X. Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19. Front Med (Lausanne). 2020;7:584342. [PMID: 33195339 DOI: 10.3389/fmed.2020.584342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
106 Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: The current evidence. United European Gastroenterol J. 2020;8:509-519. [PMID: 32450787 DOI: 10.1177/2050640620924157] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 34.5] [Reference Citation Analysis]
107 Huang J, Cheng A, Kumar R, Fang Y, Chen G, Zhu Y, Lin S. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol. 2020;92:2152-2158. [PMID: 32406952 DOI: 10.1002/jmv.26003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 36.5] [Reference Citation Analysis]
108 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
109 Ye Z, Song B. COVID-19 Related Liver Injury: Call for International Consensus. Clin Gastroenterol Hepatol. 2020;18:2848-2851. [PMID: 32425707 DOI: 10.1016/j.cgh.2020.05.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
110 Huang J, Cheng A, Lin S, Zhu Y, Chen G. Individualized prediction nomograms for disease progression in mild COVID-19. J Med Virol 2020;92:2074-80. [PMID: 32369205 DOI: 10.1002/jmv.25969] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
111 Li T, Guo Y, Zhuang X, Huang L, Zhang X, Wei F, Yang B. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin. Saudi J Gastroenterol 2020;26:272-8. [PMID: 32769260 DOI: 10.4103/sjg.SJG_239_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
112 Frager SZ, Szymanski J, Schwartz JM, Massoumi HS, Kinkhabwala M, Wolkoff AW. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis. Hepatol Commun. 2020;5:424-433. [PMID: 33681677 DOI: 10.1002/hep4.1648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
113 Liu C, Wang Z, Wu W, Xiang C, Wu L, Li J, Hou W, Sun H, Wang Y, Nie Z, Gao Y, Zhang R, Tang H, Wang Q, Li K, Xia X, Li P, Wang S. Laboratory Testing Implications of Risk-Stratification and Management of COVID-19 Patients. Front Med (Lausanne) 2021;8:699706. [PMID: 34485335 DOI: 10.3389/fmed.2021.699706] [Reference Citation Analysis]
114 Abdelrahman MM, Abdel-Baset AA, Younis MA, Mahmoud MG, Shafik NS. Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study. Clin Exp Hepatol 2021;7:297-304. [PMID: 34712832 DOI: 10.5114/ceh.2021.109225] [Reference Citation Analysis]
115 Cabibbo G, Rizzo GEM, Stornello C, Craxì A. SARS-CoV-2 infection in patients with a normal or abnormal liver. J Viral Hepat 2021;28:4-11. [PMID: 33190321 DOI: 10.1111/jvh.13440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
116 Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob 2020;19:18. [PMID: 32414383 DOI: 10.1186/s12941-020-00362-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 35.0] [Reference Citation Analysis]
117 Ding R, Yang Z, Huang D, Wang Y, Li X, Zhou X, Yan L, Lu W, Zhang Z. Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19. Int J Med Sci 2021;18:1207-15. [PMID: 33526982 DOI: 10.7150/ijms.47494] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
118 Feng X, Xie X, Song S, Chen W, Bian H, Rui F, Zhu Q, Ren W, Qin C, Qi J. Current directions, conceptions and viewpoints on 2019-nCoV (Review). Exp Ther Med 2021;21:70. [PMID: 33365070 DOI: 10.3892/etm.2020.9502] [Reference Citation Analysis]
119 Biju D, Johnson S, Valsan C, Prasad AB, Kuttichira P. Clinicoepidemiological and laboratory findings of COVID positive patients presenting to a tertiary care centre in South India: A retrospective analysis. Clin Epidemiol Glob Health 2022;13:100931. [PMID: 34926868 DOI: 10.1016/j.cegh.2021.100931] [Reference Citation Analysis]
120 Shen L, Liu F, Huang L, Liu G, Zhou L, Peng L. VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares. Comput Biol Med 2021;140:105119. [PMID: 34902608 DOI: 10.1016/j.compbiomed.2021.105119] [Reference Citation Analysis]
121 Zaky S, Alboraie M, El Badry M, Metwally MA, Abdelaziz A, Fouad Y, Abd-Elsalam S, Mahmoud A, Shiha G, Baki AA, El Kassas M, Esmat G. Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egypt Liver J 2021;11:21. [PMID: 34777868 DOI: 10.1186/s43066-021-00091-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Muntsant A, Giménez-Llort L. Impact of Social Isolation on the Behavioral, Functional Profiles, and Hippocampal Atrophy Asymmetry in Dementia in Times of Coronavirus Pandemic (COVID-19): A Translational Neuroscience Approach. Front Psychiatry 2020;11:572583. [PMID: 33329110 DOI: 10.3389/fpsyt.2020.572583] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
123 Zhai G, Li M, Wang Y, Wu J. Drug-Induced Liver Disturbance During the Treatment of COVID-19. Front Pharmacol 2021;12:719308. [PMID: 34483929 DOI: 10.3389/fphar.2021.719308] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
124 Nicolau J, Ayala L, Sanchís P, Rodríguez I, Romano A, Dotres K, Pujol A, Masmiquel L. The coexistence of low albumin levels and obesity worsens clinical outcomes among subjects admitted for sars-cov-2 infection. Clin Nutr ESPEN 2021;46:434-8. [PMID: 34857231 DOI: 10.1016/j.clnesp.2021.09.722] [Reference Citation Analysis]
125 Haritha CV, Sharun K, Jose B. Ebselen, a new candidate therapeutic against SARS-CoV-2. Int J Surg 2020;84:53-6. [PMID: 33120196 DOI: 10.1016/j.ijsu.2020.10.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
126 Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M;  APASL COVID Task Force; APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020;14:690-700. [PMID: 32623632 DOI: 10.1007/s12072-020-10072-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 29.5] [Reference Citation Analysis]
127 Cai Y, Ye LP, Song YQ, Mao XL, Wang L, Jiang YZ, Que WT, Li SW. Liver injury in COVID-19: Detection, pathogenesis, and treatment. World J Gastroenterol 2021; 27(22): 3022-3036 [PMID: 34168405 DOI: 10.3748/wjg.v27.i22.3022] [Reference Citation Analysis]
128 Lozano-Sepulveda SA, Galan-Huerta K, Martínez-Acuña N, Arellanos-Soto D, Rivas-Estilla AM. SARS-CoV-2 another kind of liver aggressor, how does it do that? Ann Hepatol 2020;19:592-6. [PMID: 32858226 DOI: 10.1016/j.aohep.2020.08.062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
129 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Reference Citation Analysis]
130 Vranić L, Radovan A, Poropat G, Mikolašević I, Milić S. Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. Medicina (Kaunas) 2021;57:1057. [PMID: 34684094 DOI: 10.3390/medicina57101057] [Reference Citation Analysis]
131 Kumar V, Kancharla S, Jena MK. In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19. Virusdisease 2021;:1-9. [PMID: 33532517 DOI: 10.1007/s13337-020-00643-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
132 An YW, Yuan B, Wang JC, Wang C, Liu TT, Song S, Liu HQ. Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19. Int J Med Sci. 2021;18:646-651. [PMID: 33437199 DOI: 10.7150/ijms.52664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
133 Nagoor Meeran MF, Seenipandi A, Javed H, Sharma C, Hashiesh HM, Goyal SN, Jha NK, Ojha S. Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? Heliyon 2021;7:e05703. [PMID: 33490659 DOI: 10.1016/j.heliyon.2020.e05703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Med 2020;18:215. [PMID: 32664944 DOI: 10.1186/s12916-020-01685-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
135 Deb S, Arrighi S. Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients. Eur J Drug Metab Pharmacokinet 2021;46:185-203. [PMID: 33538960 DOI: 10.1007/s13318-020-00668-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
136 Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Microbiota and Its Impact on the Immune System in COVID-19-A Narrative Review. J Clin Med 2021;10:4537. [PMID: 34640553 DOI: 10.3390/jcm10194537] [Reference Citation Analysis]
137 Qiu Q, Huang Y, Liu X, Huang F, Li X, Cui L, Luo H, Luo L. Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review. Front Pharmacol 2020;11:570893. [PMID: 33343347 DOI: 10.3389/fphar.2020.570893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
138 Daisley H Jr, Rampersad A, Daisley M, Ramdin A, Acco O, Narinesingh F, Humphrey O. COVID-19: a closer look at the pathology in two autopsied cases. Is the pericyte at the center of the pathological process in COVID-19? Autops Case Rep 2021;11:e2021262. [PMID: 34307223 DOI: 10.4322/acr.2021.262] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J 2021;19:32. [PMID: 34011381 DOI: 10.1186/s12959-021-00284-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Aly MM, Meshref TS, Abdelhameid MA, Ahmed SA, Shaltout AS, Abdel-Moniem AE, Hamad DA. Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study. J Blood Med 2021;12:505-15. [PMID: 34234607 DOI: 10.2147/JBM.S316681] [Reference Citation Analysis]
141 Renaud-Picard B, Gallais F, Riou M, Chatron E, Degot T, Freudenberger S, Porzio M, Schuller A, Stauder J, Hirschi S, Kessler R. The social and clinical impact of the COVID-19 epidemic on the Strasbourg lung transplant cohort: A single-center retrospective cohort study. Clin Transplant 2020;34:e14119. [PMID: 33048391 DOI: 10.1111/ctr.14119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
142 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
143 Luglio M, Tannuri U, de Carvalho WB, Bastos KLM, Rodriguez IS, Johnston C, Delgado AF. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients. Clinics (Sao Paulo) 2020;75:e2250. [PMID: 33206767 DOI: 10.6061/clinics/2020/e2250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Gupta A, Pradhan A, Maurya VK, Kumar S, Theengh A, Puri B, Saxena SK. Therapeutic approaches for SARS-CoV-2 infection. Methods 2021:S1046-2023(21)00126-2. [PMID: 33962011 DOI: 10.1016/j.ymeth.2021.04.026] [Reference Citation Analysis]
145 Asim M, Rahatullah A, Wahid K, Wahid F. Investigating the interrelatedness of clinical and non-clinical parameters affecting outcomes in COVID-19 patients: a retrospective study. Pathog Glob Health 2022;:1-7. [PMID: 35469550 DOI: 10.1080/20477724.2022.2064796] [Reference Citation Analysis]
146 Panchal D, Kataria J, Patel K, Crowe K, Pai V, Azizogli AR, Kadian N, Sanyal S, Roy A, Dodd-O J, Acevedo-Jake AM, Kumar VA. Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV. Adv Ther (Weinh) 2021;:2100104. [PMID: 34514085 DOI: 10.1002/adtp.202100104] [Reference Citation Analysis]
147 Li D, Ding X, Xie M, Tian D, Xia L. COVID-19-associated liver injury: from bedside to bench. J Gastroenterol. 2021;56:218-230. [PMID: 33527211 DOI: 10.1007/s00535-021-01760-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
148 Fallatah HI, Al Ghamdi WS, Al Dosari SM, Jabbad AH, Fagih M, Akbar HO. Association of COVID-19 with Hepatic Injury Prevalence and Associated Factors. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.121160] [Reference Citation Analysis]